These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond. Karas-Kuzelicki N; Mlinaric-Rascan I Pharmacogenomics; 2009 Aug; 10(8):1309-22. PubMed ID: 19663675 [TBL] [Abstract][Full Text] [Related]
27. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come. Ford LT; Berg JD J Clin Pathol; 2010 Apr; 63(4):288-95. PubMed ID: 20354201 [TBL] [Abstract][Full Text] [Related]
28. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. Kurzawski M; Dziewanowski K; Gawrońska-Szklarz B; Domański L; Droździk M Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099 [TBL] [Abstract][Full Text] [Related]
29. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Cao Q; Zhu Q; Shang Y; Gao M; Si J Digestion; 2009; 79(1):58-63. PubMed ID: 19252404 [TBL] [Abstract][Full Text] [Related]
30. [The usefulness of pharmacogenetics for a more individualized treatment. The example thiopurines in inflammatory bowel disease and childhood leukemia]. Lindqvist Appell M; Mårtensson LG; Almer S; Peterson C Lakartidningen; 2015 Jun; 112():. PubMed ID: 26126006 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamics. Hartford C; Vasquez E; Schwab M; Edick MJ; Rehg JE; Grosveld G; Pui CH; Evans WE; Relling MV Cancer Res; 2007 May; 67(10):4965-72. PubMed ID: 17510427 [TBL] [Abstract][Full Text] [Related]
32. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia. Chrzanowska M; Kuehn M; Januszkiewicz-Lewandowska D; Kurzawski M; Droździk M Acta Pol Pharm; 2012; 69(3):405-10. PubMed ID: 22594254 [TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status. Stocco G; Crews KR; Evans WE Expert Opin Drug Saf; 2010 Jan; 9(1):23-37. PubMed ID: 20021291 [TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics and individualized drug therapy. Eichelbaum M; Ingelman-Sundberg M; Evans WE Annu Rev Med; 2006; 57():119-37. PubMed ID: 16409140 [TBL] [Abstract][Full Text] [Related]
36. Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal. Alves S; Prata MJ; Ferreira F; Amorim A Pharmacogenetics; 1999 Apr; 9(2):257-61. PubMed ID: 10376773 [TBL] [Abstract][Full Text] [Related]
37. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783 [TBL] [Abstract][Full Text] [Related]
38. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis. Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415 [TBL] [Abstract][Full Text] [Related]
39. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Lennard L; Van Loon JA; Lilleyman JS; Weinshilboum RM Clin Pharmacol Ther; 1987 Jan; 41(1):18-25. PubMed ID: 3467886 [TBL] [Abstract][Full Text] [Related]
40. Phenome-wide association studies on a quantitative trait: application to TPMT enzyme activity and thiopurine therapy in pharmacogenomics. Neuraz A; Chouchana L; Malamut G; Le Beller C; Roche D; Beaune P; Degoulet P; Burgun A; Loriot MA; Avillach P PLoS Comput Biol; 2013; 9(12):e1003405. PubMed ID: 24385893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]